Lily Dara

2.5k total citations · 1 hit paper
32 papers, 1.8k citations indexed

About

Lily Dara is a scholar working on Pharmacology, Epidemiology and Hepatology. According to data from OpenAlex, Lily Dara has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 12 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in Lily Dara's work include Drug-Induced Hepatotoxicity and Protection (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Lily Dara is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Lily Dara collaborates with scholars based in United States, United Kingdom and France. Lily Dara's co-authors include Neil Kaplowitz, Andrea Iorga, Cheng Ji, Layla Shojaie, Zhang‐Xu Liu, Derick Han, Sanda Win, Joseph K. Lim, Jo Suda and Heather S. Johnson and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Lily Dara

30 papers receiving 1.7k citations

Hit Papers

Cell Death in Liver Diseases: A Review 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lily Dara United States 16 662 604 589 355 283 32 1.8k
Tin Aung Than United States 17 1.1k 1.7× 549 0.9× 599 1.0× 561 1.6× 240 0.8× 26 2.1k
Sanda Win United States 20 1.2k 1.8× 751 1.2× 848 1.4× 645 1.8× 245 0.9× 30 2.5k
Kazuyoshi Kon Japan 20 778 1.2× 526 0.9× 386 0.7× 500 1.4× 158 0.6× 52 1.6k
Behnam Saberi United States 18 592 0.9× 535 0.9× 439 0.7× 648 1.8× 58 0.2× 76 1.8k
Francisco Javier Cubero Spain 32 1.3k 1.9× 381 0.6× 937 1.6× 793 2.2× 235 0.8× 90 2.9k
Mohammed Bourdi United States 27 461 0.7× 1.3k 2.2× 480 0.8× 702 2.0× 131 0.5× 38 2.3k
Masayuki Adachi Japan 24 588 0.9× 158 0.3× 810 1.4× 287 0.8× 135 0.5× 49 1.9k
Desong Kong China 24 582 0.9× 175 0.3× 796 1.4× 464 1.3× 96 0.3× 51 1.8k
Benjamin L. Woolbright United States 28 857 1.3× 839 1.4× 915 1.6× 728 2.1× 125 0.4× 64 2.8k
Seiichiro Kamimura Japan 16 677 1.0× 240 0.4× 396 0.7× 283 0.8× 112 0.4× 45 1.6k

Countries citing papers authored by Lily Dara

Since Specialization
Citations

This map shows the geographic impact of Lily Dara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Dara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Dara more than expected).

Fields of papers citing papers by Lily Dara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily Dara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Dara. The network helps show where Lily Dara may publish in the future.

Co-authorship network of co-authors of Lily Dara

This figure shows the co-authorship network connecting the top 25 collaborators of Lily Dara. A scholar is included among the top collaborators of Lily Dara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily Dara. Lily Dara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mallepally, Niharika, Layla Shojaie, Evanthia T. Roussos Torres, et al.. (2025). High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers. Liver International. 45(9). e70255–e70255.
2.
Dara, Lily, et al.. (2025). Immune‐Mediated Liver Injury From Checkpoint Inhibitor: An Evolving Frontier With Emerging Challenges. Liver International. 45(2). e16198–e16198. 5 indexed citations
3.
Dara, Lily & Marwan Ghabril. (2024). A state-of-the-art update on hepatotoxicity: Introduction to the special series on drug-induced liver injury. Clinical Liver Disease. 23(1). 1 indexed citations
4.
Shojaie, Layla, Sue Murray, Gary C. Kanel, et al.. (2024). Innate and adaptive immune cell interaction drives inflammasome activation and hepatocyte apoptosis in murine liver injury from immune checkpoint inhibitors. Cell Death and Disease. 15(2). 140–140. 10 indexed citations
5.
Flores, Daniel, Joanne Xiu, Irene Kang, et al.. (2024). Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer. Breast Cancer Research and Treatment. 206(2). 245–259. 3 indexed citations
6.
7.
Maretti‐Mira, Ana C., et al.. (2023). Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity. Frontiers in Immunology. 14. 1137034–1137034. 7 indexed citations
8.
Dara, Lily, Marwan Ghabril, Elizabeth Phillips, David E. Kleiner, & Naga Chalasani. (2023). A 68-Year-Old Woman With Unexplained Liver Enzyme Elevation and Active Chronic Hepatitis: Beware of Drug-Induced Autoimmune-Like Hepatitis. Gastroenterology. 166(2). 259–266.e1. 4 indexed citations
9.
Galle-Treger, Lauriane, Doumet Georges Helou, Christine Quach, et al.. (2022). Autophagy impairment in liver CD11c+ cells promotes non-alcoholic fatty liver disease through production of IL-23. Nature Communications. 13(1). 1440–1440. 18 indexed citations
10.
Iorga, Andrea, Katherine Donovan, Layla Shojaie, et al.. (2021). Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity. Journal of Biological Chemistry. 296. 100300–100300. 17 indexed citations
11.
Shojaie, Layla, et al.. (2021). Mechanisms of immune checkpoint inhibitor-mediated liver injury. Acta Pharmaceutica Sinica B. 11(12). 3727–3739. 56 indexed citations
12.
Lee, Brian T., Yun Wang, Alexander H. Yang, et al.. (2019). IgG:IgM Ratios of Liver Plasma Cells Reveal Similar Phenotypes of Primary Biliary Cholangitis With and Without Features of Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology. 19(2). 397–399. 8 indexed citations
13.
Iorga, Andrea, Lily Dara, & Neil Kaplowitz. (2017). Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis. International Journal of Molecular Sciences. 18(5). 1018–1018. 230 indexed citations
14.
Suda, Jo, Lily Dara, Mariam Aghajan, et al.. (2016). Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB. The Journal of Immunology. 197(8). 3120–3129. 45 indexed citations
15.
Sadtler, Bryce, G. Esteban Fernández, Lily Dara, et al.. (2014). Cellular uptake and cytotoxicity of a near-IR fluorescent corrole–TiO2 nanoconjugate. Journal of Inorganic Biochemistry. 140. 39–44. 15 indexed citations
16.
Han, Derick, Lily Dara, Sanda Win, et al.. (2013). Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends in Pharmacological Sciences. 34(4). 243–253. 146 indexed citations
17.
Han, Derick, Maria D. Ybanez, Heather S. Johnson, et al.. (2012). Dynamic Adaptation of Liver Mitochondria to Chronic Alcohol Feeding in Mice: BIOGENESIS, REMODELING, AND FUNCTIONAL ALTERATIONS. The Journal of Biochemistry. 287. 4 indexed citations
18.
Han, Derick, Maria D. Ybanez, Heather S. Johnson, et al.. (2012). Dynamic Adaptation of Liver Mitochondria to Chronic Alcohol Feeding in Mice. Journal of Biological Chemistry. 287(50). 42165–42179. 69 indexed citations
19.
Dara, Lily, Cheng Ji, & Neil Kaplowitz. (2011). The contribution of endoplasmic reticulum stress to liver diseases. Hepatology. 53(5). 1752–1763. 305 indexed citations
20.
Dara, Lily, et al.. (2008). Hydroxycut hepatotoxicity: A case series and review of liver toxicity from herbal weight loss supplements. World Journal of Gastroenterology. 14(45). 6999–6999. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026